Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

By Vena Gino A.   Galluccio Antonia   Pezza Michele   Vestita Michelangelo   Cassano Nicoletta  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 255-260

Informa Healthcare

Access to resources Recommend Favorite

Safety of Efalizumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: Review of Clinical Data. Part II

By Papp Kim   Camisa Charles   Stone Stephen   Caro Ivor   Wang Xiaolin   Compton Peter   Walicke Patricia   Gottlieb Alice  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 313-323

Springer Publishing Company

Access to resources Recommend Favorite

A retrospective analysis of combination methotrexate–cyclosporine therapy in moderate–severe psoriasis

By Mohanan Saritha   Ramassamy Sivaranjini   Chandrashekar Laxmisha   Thappa Devinder Mohan  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 50-53

Informa Healthcare

Access to resources Recommend Favorite

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis

By Martin Silas   Feldman Steven R.   Augustin Matthias   Szapary Philippe   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 22, Iss. 3, 2011-06 ,pp. : 138-143

Informa Healthcare

Access to resources Recommend Favorite

Reliability and validity of the psoriasis symptom inventory in patients with moderate-to-severe psoriasis

By Revicki Dennis A.   Jin Ying   Wilson Hilary D.   Chau Dina   Viswanathan Hema N.  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 8-14

Informa Healthcare

Access to resources Recommend Favorite